Daniel & Daniel Consulting · Class II · Cleared Feb 25, 2014
| K-number | K132389 |
| Device name | CELLVIZIO 100 SERIES SYSTEM AND CELLVIZIO SYSTEM WITH CONFOCAL MINIPROBES; UROFLEX B AND CYSTOLFLEX F (BOTH TRADE MARKED |
| Applicant | Daniel & Daniel Consulting |
| Product code | OWN |
| Device class | Class II |
| Decision date | Feb 25, 2014 |
| Decision | Substantially Equivalent |
| Regulation | 876.1500 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov